Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2091]
News [6477]
Articles [133]
Editorials [5]
Conferences [171]
elearning [10]
Radiogenomic evaluation of tumour response to targeted agents
Dr Ronald Korn - CMO and founder of Imaging Endpoints, Scottsdale, USA
Radiogenomic evaluation of tumour response to targeted agents ( Dr Ronald Korn - CMO and founder of Imaging Endpoints, Scottsdale, USA )
10 Mar 2015
Drugging the cancer genome to overcome drug resistance
Prof Paul Workman - Institute of Cancer Research, UK
Drugging the cancer genome to overcome drug resistance ( Prof Paul Workman - Institute of Cancer Research, UK )
10 Mar 2015
ecancermedicalscience editor's choice for February 2015
Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ecancermedicalscience editor's choice for February 2015 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
3 Mar 2015
Expert commentary on emerging research in genitourinary cancer
Dr Chris Parker - The Royal Marsden Hospital, London, UK
Expert commentary on emerging research in genitourinary cancer ( Dr Chris Parker - The Royal Marsden Hospital, London, UK )
28 Feb 2015
Combination of dalantercept plus axitinib versus placebo plus axitinib in...
Dr Martin Voss - Memorial Sloan Kettering Cancer Centre, New York City, USA
Combination of dalantercept plus axitinib versus placebo plus axitinib in advanced clear cell renal cell carcinoma ( Dr Martin Voss - Memorial Sloan Kettering Cancer Centre, New York City, USA )
28 Feb 2015
Combination of abiraterone and cabazitaxel in metastatic castration-resistant...
Dr Joaquin Mateo - Institute of Cancer Research, London, UK
Combination of abiraterone and cabazitaxel in metastatic castration-resistant prostate cancer ( Dr Joaquin Mateo - Institute of Cancer Research, London, UK )
27 Feb 2015
Basal subtype predicts clinical benefit from neoadjuvant chemo in urothelial...
Dr Arlene Siefker-Radtke - MD Anderson Cancer Centre, Houston, USA
Basal subtype predicts clinical benefit from neoadjuvant chemo in urothelial cancer ( Dr Arlene Siefker-Radtke - MD Anderson Cancer Centre, Houston, USA )
27 Feb 2015
ASCO GU 2015: Review of the latest data in prostate cancer
Prof Eleni Efstathiou, Prof Charles Ryan, Dr Heather Payne
ASCO GU 2015: Review of the latest data in prostate cancer ( Prof Eleni Efstathiou, Prof Charles Ryan, Dr Heather Payne )
27 Feb 2015
ASCO GU 2015: Prostate highlights from day one
Prof Karim Fizazi, Prof Kurt Miller, Dr Maria De Santis, Dr Mark Rubin
ASCO GU 2015: Prostate highlights from day one ( Prof Karim Fizazi, Prof Kurt Miller, Dr Maria De Santis, Dr Mark Rubin )
26 Feb 2015
Metastatic prostate cancer - Interpreting negative trial results
Prof Stephane Oudard and Prof Noel Clarke
Metastatic prostate cancer - Interpreting negative trial results ( Prof Stephane Oudard and Prof Noel Clarke )
26 Feb 2015
Efficacy, tolerability and quality of life in metastatic renal cell carcinoma:...
Prof Bernard Escudier - Institut Gustave-Roussy, Paris, France
Efficacy, tolerability and quality of life in metastatic renal cell carcinoma: Welcome and introduction ( Prof Bernard Escudier - Institut Gustave-Roussy, Paris, France )
11 Feb 2015
mRCC: Are we doing all we can to manage adverse events?
Prof Bernard Escudier - Institut Gustave-Roussy, Paris, France
mRCC: Are we doing all we can to manage adverse events? ( Prof Bernard Escudier - Institut Gustave-Roussy, Paris, France )
11 Feb 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation